Assessment of the predictive role of pretreatment Ki-67 and Ki-67 changes in breast cancer patients receiving neoadjuvant chemotherapy according to the molecular classification: a retrospective study of 1010 patients

Rui Chen(First Affiliated Hospital of Chongqing Medical University), Shengchun Liu(The Affiliated Yongchuan Hospital of Chongqing Medical University), Xinliang Su(The Affiliated Yongchuan Hospital of Chongqing Medical University), Beige Zong(First Affiliated Hospital of Chongqing Medical University), Yihua Wang(The Affiliated Yongchuan Hospital of Chongqing Medical University), Zhenrong Tang(The Affiliated Yongchuan Hospital of Chongqing Medical University), Chengcheng Yang(Harbin Medical University), Guanglun Yang(The Affiliated Yongchuan Hospital of Chongqing Medical University), Ye Yin(The Affiliated Yongchuan Hospital of Chongqing Medical University), Yang Peng(Liaocheng University), Hongyuan Li(Central South University), Fanli Qu(German Cancer Research Center)
Breast Cancer Research and Treatment
February 26, 2018
10.1007/s10549-018-4730-1
Cited by 74

Related Papers

Increased NF-κB signalling up-regulates BACE1 expression and its therapeutic potential in Alzheimer's disease
|The International Journal of Neuropsychopharmacology|2011|430
Acquired CDK6 amplification promotes breast cancer resistance to CDK4/6 inhibitors and loss of ER signaling and dependence
|Oncogene|2016|430
Sulfasalazine‑induced ferroptosis in breast cancer cells is reduced by the inhibitory effect of estrogen receptor on the transferrin receptor
|Oncology Reports|2019|223
Acquisition of epithelial-mesenchymal transition phenotype in the tamoxifen-resistant breast cancer cell: a new role for G protein-coupled estrogen receptor in mediating tamoxifen resistance through cancer-associated fibroblast-derived fibronectin and β1-integrin signaling pathway in tumor cells
|Breast Cancer Research|2015|120
Diagnostic Value of Circulating Chromogranin A for Neuroendocrine Tumors: A Systematic Review and Meta-Analysis
|PLoS ONE|2015|101